Join the Status Epilepticus group to help and get support from people like you.
Status Epilepticus News
Treatment Response to Antiseizure Medications Can Take More Than One Year
WEDNESDAY, Aug. 27, 2025 – Many people with newly diagnosed focal episodes take more than one year and more than one antiseizure medication (ASM) to become seizure-free, according to a study...
It Takes About A Year To Get Epilepsy Under Control For Most, Study Says
TUESDAY, Aug. 26, 2025 — It takes about a year for people with focal epilepsy to start finding some relief from anti-seizure medications, a new study says. In all, 3 of 5 epilepsy patients (60%) do a...
Sleep Apnea Increases Sudden Cardiac Arrest Risk in Children With Epilepsy
FRIDAY, Aug. 22, 2025 – For pediatric patients with epilepsy, sleep apnea (SA) is associated with an increased risk for sudden cardiac arrest (SCA) and cardiac dysrhythmia, according to a study...
Antiseizure Meds With Known or Uncertain Risks Continue to Be Prescribed in Pregnancy
MONDAY, July 28, 2025 – Despite a shift from valproate to safer antiseizure medications (ASMs) in pregnancy, many medications with known or uncertain risks are still being prescribed, according to a...
Epilepsy Associated With Poor Brain Health
FRIDAY, Jan. 10, 2025 – Epilepsy is associated with poor brain health, with a consistent deleterious effect seen on cognitive and motor function and mental health, according to a study published...
FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients
PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved Sesquient (fosphenytoin sodium for i...